Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
Trial Parameters
Brief Summary
The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.
Eligibility Criteria
Inclusion Criteria: * Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report * Written informed consent from the patient or family representative; * Individuals who own smartphone and are capable of using wechat or apps Exclusion Criteria: * Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease * With mental disorders * Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial